To achieve complete polio eradication, the live oral poliovirus vaccine (OPV) currently used must be phased out after the end of wild poliovirus transmission. However, poorly understood threats may arise when OPV use is stopped. To counter these threats, better models than those currently available are needed. Two articles recently published in BMC Medicine address these issues. Mercer et al. (BMC Med 15:180, 2017) developed a statistical model analysis of polio case data and characteristics of cases occurring in several districts in Pakistan to inform resource allocation decisions. Nevertheless, despite having the potential to accelerate the elimination of polio cases, their analyses are unlikely to advance our understanding OPV cessation threats. McCarthy et al. (BMC Med 15:175, 2017) explored one such threat, namely the emergence and transmission of serotype 2 circulating vaccine derived poliovirus (cVDPV2) after OPV2 cessation, and found that the risk of persistent spread of cVDPV2 to new areas increases rapidly 1–5 years after OPV2 cessation. Thus, recently developed models and analysis methods have the potential to guide the required steps to surpass these threats. ‘Big data’ scientists could help with this; however, datasets covering all eradication efforts should be made readily available.
WHO: WHO Global Action Plan to minimize poliovirus facility-associated risk (GAPIII). In . Edited by Organization WH. Geneva: WHO; 2015.
GPEI: Global Polio Eradication Initiative Annual Report 2016. In: Polio Eradication. http://polioeradication.org/wp-content/uploads/2017/08/AR2016_EN.pdf: WHO; 2016. Accessed 14 Dec 2017.
GPEI: Circulating vaccine-derived poliovirus. In: Polio Eradication. http://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus/: WHO; 2017: Table of cVDPV cases per year. Accessed 14 Dec 2017.
Mercer LD, Safdar RM, Ahmed J, Mahamud A, Kahn MM, Gerber S, O’Leary A, Ryan M, Salet F, Kroiss SJ, et al. Spatial Model for Risk Prediction and Sub-National Prioritization to Aid Poliovirus Eradication in Pakistan. BMC Medicine. 2017;15(1):180. doi: 10.1186/s12916-017-0941-2.
McCarthy KA, Chabot-Couture G, Famulare M, Lyons HM, Mercer LD. The risk of Type 2 oral polio vaccine use in post-cessation outbreak response. BMC Med. 2017.
King AA, Nguyen D, Ionides EL: Statistical Inference for Partially Observed Markov Processes via the R Package pomp. J Stat Softw. 2016, 69(12).
Koopman JS, Singh P, Ionides EL: Transmission Modeling To Enhance Surveillance System Function. In: Transforming Public Health Surveillance: Proactive Measures for Prevention, Detection, and Response. edn. Edited by McNabb SJN: Elsevier; 2016.
- Models and analyses to understand threats to polio eradication
James S. Koopman
- BioMed Central
Neu im Fachgebiet Allgemeinmedizin
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II